Investigational drug · Phase 3
DIPYRONE
Not approved by FDA. In 2 industry-sponsored Phase 2 or 3 trials that are active or finished in the last two years, most often for Moderate Pain, Severe Pain, Common Cold/Flu.
Phase 3Last checked: Nov 19, 2026Latest source record: Jun 16, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations
Highest phase
Phase 3
Industry-sponsored trials
Phase 2 and 3 trials
2
2 still active
All registered trials
98
Any phase or sponsor naming "DIPYRONE"
First trial start
2025
Feb 15, 2025
Sponsors
Lead sponsors of its Phase 2 and 3 trials.
- EMS1
All registered trials by phase
Every ClinicalTrials.gov drug study naming "DIPYRONE", any sponsor or status.
- Phase 317
Conditions studied
As listed on its trial records.
- Moderate Pain
- Severe Pain
- Common Cold/Flu
- Nasal Congestion
- Nasal Obstruction
Approved drugs for the same conditions: Pain and anesthesia
Largest trials
Live from ClinicalTrials.gov: studies naming "DIPYRONE" as an intervention, largest first.
- Long-term Opioid Therapy, Misuse and Mortality in Patients With Chronic Non-cancer Pain in GermanyCompleted
LinkCare GmbHIndustry
NCT03778450 · 3,232 participants · Start Dec 5, 2018 · Primary completion Aug 31, 2019
Drug: Analgesics, Opioid; Non-Opioid Analgesic · For: Pain
Sites: Stuttgart, Germany
- Aseptic Meningoencephalitis in SloveniaStatus unknown
University Medical Centre LjubljanaAcademic, hospital or other
NCT02328469 · 800 participants (planned) · Start Jun 2014 · Primary completion Jun 2020
Drug: symptomatic therapy; Ceftriaxone or Doxycycline and 1 more · For: Aseptic Meningitis
Sites: Ljubljana, Slovenia · 2 sites in all
University Medical Centre LjubljanaAcademic, hospital or other
NCT03958058 · 690 participants · Start Jan 1, 2007 · Primary completion Dec 31, 2013
Drug: Anti-borrelial antibiotic therapy · For: Tick Borne Encephalitis; Lyme Disease
Sites: Ljubljana, Slovenia
- Fixed-dose Combination of 1000 mg Dipyrone Monohydrate + 60 mg Caffeine + 4 mg Chlorpheniramine Maleate in Improving Symptoms of the Common Cold and Flu in AdultsPivotal-lookingRecruiting
Brainfarma Industria Química e Farmacêutica S/AIndustry
NCT07626437 · 620 participants (planned) · Start May 8, 2026 · Primary completion Jun 28, 2027
Drug: dipyrone monohydrate 1000 mg + chlorpheniramine maleate 4 mg + caffeine 60 mg; dipyrone monohydrate 500 mg + chlorpheniramine maleate 2 mg + caffeine 30 mg and 1 more · For: Common Cold/Flu; Nasal Congestion; Nasal Obstruction
Sites: Belo Horizonte, Brazil; Vespasiano, Brazil; Belém, Brazil · 15 sites in all
- Fixed Combination of Dipyrone and Codeine for Controlling Pain After Pelvic-abdominal SurgeryPivotal-lookingCompleted
Brazilian Clinical Research InstituteAcademic, hospital or other
NCT04641338 · 491 participants · Start Mar 16, 2023 · Primary completion Mar 15, 2024
Drug: Fixed dose combination Dipyrone and Codeine; Dipyrone and 1 more · For: Pain, Postoperative
Sites: Ijuí, Brazil; Bragança Paulista, Brazil; Votuporanga, Brazil
- Efficacy and Tolerability of Metamizol in Patients With Episodic Moderate HeadachePivotal-lookingCompleted
Boehringer IngelheimBoehringer Ingelheim
NCT02183220 · 417 participants · Start Oct 1998 · Primary completion Jul 1999
Drug: Metamizol; Acetylsalicylic acid (ASA) and 2 more · For: Migraine Disorders
- Ibuprofen, Acetaminophen and Dipyrone to Fever Control in ChildrenPivotal-lookingCompleted
Mantecorp Industria Quimica e Farmaceutica Ltd.Industry
NCT01359020 · 396 participants · Start Jan 2007 · Primary completion Mar 2008
Drug: ibuprofen, dipyrone, acetaminophen · For: Fever
Sites: Recife, Brazil
- Efficacy of Non-opioid Drugs in Addition to Opioid Therapy for Cancer Pain ManagementPivotal-lookingNot yet recruiting
University Hospital, Basel, SwitzerlandAcademic, hospital or other
NCT07682558 · 318 participants (planned) · Start Oct 2026 · Primary completion Nov 2029
Drug: Metamizole; Ibuprofen · For: Cancer Pain; Cancer Palliative Care
Sites: Basel, Switzerland
- Efficacy and Safety of Induction Strategies Combined With Low Tacrolimus Exposure in Kidney Transplant Recipients Receiving Everolimus or Sodium MycophenolatePivotal-lookingCompleted
Hospital do Rim e HipertensãoAcademic, hospital or other
NCT01354301 · 300 participants · Start May 2011 · Primary completion Apr 2014
Drug: Thymoglobulin; Everolimus and 5 more · For: Cytomegalovirus Infection; Renal Transplant Failure; Transplant; Complication, Rejection
Sites: São Paulo, Brazil
- Fixed Dose Combination of COdeine + DIpyrone to Mitigate Moderate to Intense Pain Post-impacted Third Lower Molar ExtractionPivotal-lookingCompleted
Eurofarma Laboratorios S.A.Industry
NCT04972292 · 288 participants · Start Nov 8, 2023 · Primary completion May 28, 2024
Drug: FDC of codeine 30 mg/dipyrone 500 mg; Tylex · For: Pain
Sites: Brasil, Brazil; São Paulo, Brazil
Newest research
PubMed records naming it or its code names, newest first.
- Prevalence and clinical characterization of headache in patients with cranial bone defects: a single-center retrospective study.
de Oliveira Manduca Palmiero H, Rosi J, da Silva SA, et al. · Acta Neurol Belg 2026
- Ultrasound-guided transversus abdominis plane (Tap) block catheterization for continuous analgesia in canine pancreatitis: Case report.
Freitas CHG, Magalhães VG, Quintanilha VDC, et al. · Braz J Vet Med 2026
- Evaluating protein modification as a shared mechanism in drug-induced agranulocytosis: In vitro studies with five chemically diverse drugs.
Liu H, Tran NH, Lockhart S, et al. · Toxicology 2026
- Metamizole (dipyrone) versus ibuprofen for post-cesarean analgesia in women with preeclampsia with severe features: a quadruple-blind, randomized, active-comparator trial.
Pordeus ACB, Katz L, Maia MT, et al. · Am J Obstet Gynecol MFM 2026
- Maternal Pharmaceutical Intake, Tobacco Smoking, and Environmental Pesticide Exposures: High-Resolution Serum Pesticide Screening, Longitudinal Fetal Ultrasound Biometry, and Postnatal Anogenital Distance in a Brazilian Cohort.
Sater AC, da Silva AM, de Moraes IC, et al. · Biology (Basel) 2026
- Comparative effects of stem and leaf extracts from Pereskia aculeata (ora-pro-nóbis) on skeletal muscle, kidney and liver following hind limb ischemia-reperfusion in rats.
Vital BM, Zan Malaguti MV, Camargo MF, et al. · J Integr Med 2026
Also in development for Moderate Pain
- DIT112Phase 31 trial
EMS · Moderate Pain, Severe Pain
Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.